top of page
< Back

Efficacy and Safety: A Multi-institutional Prospective Cohort Study

Radiofrequency ablation (RFA) has been recently adopted into the practice of thyroidology in the United States, although its use as an alternative to traditional thyroid surgery in Asia and Europe came near the turn of the 21st century. In the United States, only a few studies with small sample sizes have been published to date.

Kandil, E., Omar, M., Aboueisha, M., Attia, A. S., Ali, K. M., Abu Alhuda, R. F., Issa, P. P., Wolfe, S., Omari, S., Buti, Y., Abozaid, O., Toraih, E., Shama, M. A., Lee, G., Tufano, R. P., & Russell, J. O. (2022). Efficacy and Safety of Radiofrequency Ablation of Thyroid Nodules: A Multi-institutional Prospective Cohort Study. Annals of surgery, 276(4), 589–596. https://doi.org/10.1097/SLA.0000000000005594

This study explores the use of radiofrequency ablation (RFA) or related thermal techniques for treating benign thyroid nodules. It highlights clinical outcomes, safety, and effectiveness relevant to both patients and insurance providers. Radiofrequency ablation (RFA) has been recently adopted into the practice of thyroidology in the United States, although its use as an alternative to traditional thyroid surgery in Asia and Europe came near the turn of the 21st century. In the United States, only a few studies with small sample sizes have been published to date. We examined outcomes of benign thyroid nodules treated with RFA from 2 North American institutions.

bottom of page